Fintel PLC Boosts Software & Data Division with Strategic Acquisition of Pearson Ham's Insurance Pricing Business

What it could mean for growth, margins and returns

The acquired business is described as profitable, growing and cash generative, with a “rich historic data set”. For FY26, the target is £2.6 million of revenue and £0.9 million of EBITDA, implying an EBITDA margin in the mid-30s on those disclosed expectations.

On the headline price of £11.0 million, that equates to roughly 4.2x FY26 revenue and about 12.2x FY26 EBITDA, based on the RNS figures. Whether that proves attractive will hinge on three things:

• Cross-sell and upsell: Can Defaqto sell more Matrix360 modules, ratings enhancements and analytics to existing insurer clients with the pricing data now in the stack?
• Product velocity: How quickly do “value for money” ratings and AI-led benchmarking tools reach commercial scale?
• Churn and resilience: Pricing data is sticky if it’s embedded in workflows. The stickier it is, the better the lifetime economics.

The deal is funded from Fintel’s revolving credit facility (RCF) on competitive terms, which keeps equity intact. Management explicitly flag that, after interest and tax, the acquisition will lift earnings in FY26. That suggests FY25 is likely neutral or modestly dilutive on EPS as integration and finance costs come through, but the RNS doesn’t quantify the near-term impact.

Operational angles: integration, incentives and clients

The business slots into Defaqto. Integration matters in data acquisitions – schemas, quality controls and timeliness of updates are the lifeblood of pricing intelligence. The RNS notes a separate Growth Share Plan will be implemented to retain and incentivise key managers in the acquired business. Structure and potential dilution, if any, are not disclosed.

Client-side, the logic is strong. Defaqto already counts 22 major insurers using Matrix360. Adding market pricing data should raise the platform’s utility, improve benchmarking, and potentially support additional modules. The key is execution: onboarding the pricing feeds cleanly and surfacing insights simply enough for underwriting, pricing and distribution teams to act on them.

The AI angle: data as the differentiator

Fintel is explicit that “the winners in the AI economy” will have unique, proprietary data. That rings true. Generative and agentic AI tools are only as good as the data they’re trained and tuned on. Combining product specifications with observed market pricing can power smarter “value for money” ratings and more credible benchmarking – the kind of decision support insurers, providers and price comparison sites will pay for.

The flywheel is clear: more data drives better models, better models drive better products, which attract more clients and data. If Defaqto executes, this acquisition strengthens that loop.

Risks and watch-outs for shareholders

• Integration risk: Merging pricing datasets with existing product data is non-trivial. Any disruption to data timeliness or quality could dent client trust.
• Commercialisation pace: The RNS doesn’t set targets for Matrix360 growth or “value for money” roll-out. If monetisation lags, the return profile stretches.
• Competitive response: Price comparison sites and analytics vendors won’t stand still. Defaqto’s ability to keep features fresh will be tested.
• Disclosure gaps: No purchase price allocation, synergies, or near-term EPS impact were disclosed beyond FY26 accretion. The Growth Share Plan details are also not disclosed.

Bottom line: a tidy, strategically coherent bolt-on

On the face of it, this is a neat bolt-on that deepens Defaqto’s data moat, is sensibly funded, and lines up with Fintel’s push to be the UK financial services sector’s strategic technology and data partner. It adds a growing, cash generative pricing dataset to an already strong product data franchise.

Positives: clear strategic fit, proprietary data, AI enablement, no equity raise, FY26 earnings accretion. Negatives: limited near-term EPS clarity, no synergy guidance, and the usual integration risks. If Defaqto executes on product innovation and cross-sell, this acquisition should help compound the Software & Data division’s growth through 2026.

For now, it’s a sensible swing at a high-value niche. The next proof points to watch: additional Matrix360 adoption beyond the current 22 major insurers, visible new AI-led features, and confirmation that the acquired business hits that £0.9 million FY26 EBITDA target.